Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...

Common Disorders Associated with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Knowledge of the pathogenesis, management, and outcomes of the primary TMA syndromes has accelerated in ...

The unexpected occurrence of thrombotic microangiopathy (TMA), characterized by microangiopathic hemolytic anemia and thrombocytopenia, in a patient with cancer requires urgent diagnosis and ...

Genentech has received reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin (bevacizumab) in combination with Sutent (sunitinib ...

Understanding of the pathophysiology of thrombotic microangiopathies — a group of rare yet life-threatening hematologic conditions — has evolved in recent years along with better access to diagnostic ...

These results, taken in totality, were consistent with hemolytic anemia. There were no previous laboratory results for comparison. The answer is both (a) and (e). Both microangiopathic anemia and ...

The clinical hallmarks include microangiopathic hemolytic anemia (ie, schistocytes on peripheral smear), thrombocytopenia and end-organ damage. Conditions that fall under the rubric of thrombotic ...

The cases of microangiopathic hemolytic anemia seen in a Phase 1 kidney cancer study led to the closure of a mid-stage trial of Avastin plus Sutent, Genentech said in a letter to doctors that was ...

In severe cases, aplastic anemia can lead to complications such as heart failure, leukemia, bleeding, and other blood disorders. Hemolytic anemia occurs when the body destroys oxygen-carrying red ...

Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure (1). In ∼90% of childhood cases, HUS follows ...